NASDAQ

Updated Oct 30, 8:32 AM ET

LGND

Ligand Pharmaceuticals Inc.

−$1.45 (0.45%) Thu · Closed $317.33

−$1.45 (0.46%) ☀ Pre-Market

Oct 30, 8:32 AM ET

About LGND

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Sign up free to see this.

Daily pricesFundamentals

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

Votes and Bull · Bear posts, 24h. At least 5 are needed.

How do you feel about LGND?

Board · 0 threads

Open board ›

Community opinions, not advice. Posts with a target get a receipt. How receipts work ›